![Akash Maniam: New publication in JAMA Network Open – Neoadjuvant Chemoimmunotherapy in early stage NSLC](https://oncodaily.com/pub/uploads/2023/10/IMG_9971.jpeg)
Akash Maniam: New publication in JAMA Network Open – Neoadjuvant Chemoimmunotherapy in early stage NSLC
Akash Maniam, Clinical Director at
“New publication in Journal of the American Medical Association (JAMA) Network Open – Neoadjuvant Chemoimmunotherapy in early stage non-small cell lung cancer – Systematic review and meta-analysis. So much recent work in this space, every paper adds something new. Read and enjoy! Legendary cast indeed.”
Link to paper.
Source: Akash Maniam/Linkedin
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.